US Patent

US7332183 — Multilayer dosage forms containing NSAIDs and triptans

Method of Use · Assigned to Pozen Inc · Expires 2025-10-02 · 1y expired

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a type of multilayer pharmaceutical tablet that contains an NSAID and a triptan in separate layers.

USPTO Abstract

The present invention is directed to multilayer pharmaceutical tablets in which an NSAID and a triptan are present in separate and distinct layers. The layers are in a side-by-side configuration, which allows the dissolution of triptan and NSAID to occur independently and immediately.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-867`	—
`U-1719`	—

Patent Metadata

Patent number: US7332183
Jurisdiction: US
Classification: Method of Use
Expires: 2025-10-02
Drug substance claim: No
Drug product claim: Yes
Assignee: Pozen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.